Home > Income Statement > GENPHARMASEC

GENPHARMASEC
Revenue

    Back to Income Statement
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023
Net Sales ₹30 Cr₹26 Cr₹26 Cr

What is the latest Revenue of GENPHARMASEC ?

The latest Revenue ratio of GENPHARMASEC is ₹30 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹30 Cr
Mar2024₹26 Cr
Mar2023₹26 Cr

How is Revenue of GENPHARMASEC Trending?

Years Revenue % Change
Mar2025 ₹30 Cr
19.16
Mar2024 ₹26 Cr
0.00
Mar2023 ₹26 Cr -

Compare Revenue of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹69.2 Cr -2.3% NA -42.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,083.7 Cr -1.6% 0.5% 0.8% Stock Analytics
KIRI INDUSTRIES ₹2,737.3 Cr 1.1% -5.5% -16% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,541.6 Cr -2.2% -1.5% -30.7% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,084.3 Cr -4.9% -4.7% 13.4% Stock Analytics
BODAL CHEMICALS ₹607.2 Cr 0.1% 1.7% -21.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-2.3%

NA

-42.9%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses